ITMI932540A0 - Composizione farmaceutica - Google Patents

Composizione farmaceutica

Info

Publication number
ITMI932540A0
ITMI932540A0 ITMI932540A ITMI932540A ITMI932540A0 IT MI932540 A0 ITMI932540 A0 IT MI932540A0 IT MI932540 A ITMI932540 A IT MI932540A IT MI932540 A ITMI932540 A IT MI932540A IT MI932540 A0 ITMI932540 A0 IT MI932540A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ITMI932540A
Other languages
English (en)
Inventor
Tiziana Crolla
Franco Francese
Massimo Maneschi
Diego Oldani
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of ITMI932540A0 publication Critical patent/ITMI932540A0/it
Priority to ITMI932540A priority Critical patent/IT1274241B/it
Priority to EP95903281A priority patent/EP0804168A1/en
Priority to PCT/EP1994/003903 priority patent/WO1995015155A1/en
Priority to CN94194885A priority patent/CN1145586A/zh
Priority to CA002177721A priority patent/CA2177721A1/en
Priority to NZ277238A priority patent/NZ277238A/en
Priority to AU12198/95A priority patent/AU693144B2/en
Priority to JP7515376A priority patent/JPH09505818A/ja
Priority to ZA949567A priority patent/ZA949567B/xx
Publication of ITMI932540A1 publication Critical patent/ITMI932540A1/it
Application granted granted Critical
Publication of IT1274241B publication Critical patent/IT1274241B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6943Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI932540A 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono IT1274241B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
CA002177721A CA2177721A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
PCT/EP1994/003903 WO1995015155A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
CN94194885A CN1145586A (zh) 1993-12-03 1994-11-24 含药物/聚合物复合物的味掩蔽组合物
EP95903281A EP0804168A1 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
NZ277238A NZ277238A (en) 1993-12-03 1994-11-24 Taste masked composition containing paroxetine complexed with a polymer
AU12198/95A AU693144B2 (en) 1993-12-03 1994-11-24 Taste masked composition containing a drug/polymer complex
JP7515376A JPH09505818A (ja) 1993-12-03 1994-11-24 薬/ポリマー複合体含有の風味をマスクした組成物
ZA949567A ZA949567B (en) 1993-12-03 1994-12-01 Chewable taste masked complexes containing pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI932540A0 true ITMI932540A0 (it) 1993-12-03
ITMI932540A1 ITMI932540A1 (it) 1995-06-03
IT1274241B IT1274241B (it) 1997-07-15

Family

ID=11367288

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Country Status (9)

Country Link
EP (1) EP0804168A1 (it)
JP (1) JPH09505818A (it)
CN (1) CN1145586A (it)
AU (1) AU693144B2 (it)
CA (1) CA2177721A1 (it)
IT (1) IT1274241B (it)
NZ (1) NZ277238A (it)
WO (1) WO1995015155A1 (it)
ZA (1) ZA949567B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU748804B2 (en) * 1995-07-20 2002-06-13 Smithkline Beecham Plc Paroxetine controlled release compositions
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EP0994872B9 (en) 1997-06-10 2001-12-05 Synthon B.V. 4-phenylpiperidine compounds
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
AR014133A1 (es) * 1997-12-19 2001-02-07 Smithkline Beecham Corp Procedimiento para fabricar tabletas de dispersion rapida para administracion oral y una formulacion de dichas tabletas
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ATE311883T1 (de) 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB0119467D0 (en) * 2001-08-09 2001-10-03 Smithkline Beecham Plc Novel compound
ATE321530T1 (de) * 2001-08-09 2006-04-15 Smithkline Beecham Plc Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
CA2853117C (en) * 2011-10-25 2018-08-07 Expermed S.A. Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE62407T1 (de) * 1985-08-26 1991-04-15 Procter & Gamble Geschmack abdeckende zusammensetzungen.

Also Published As

Publication number Publication date
ZA949567B (en) 1995-10-10
AU1219895A (en) 1995-06-19
EP0804168A1 (en) 1997-11-05
AU693144B2 (en) 1998-06-25
NZ277238A (en) 1998-04-27
ITMI932540A1 (it) 1995-06-03
JPH09505818A (ja) 1997-06-10
WO1995015155A1 (en) 1995-06-08
CN1145586A (zh) 1997-03-19
IT1274241B (it) 1997-07-15
CA2177721A1 (en) 1995-06-08

Similar Documents

Publication Publication Date Title
FI944832A (fi) Farmaseuttinen koostumus
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
NO20004345L (no) Farmasøytisk sammensetning
FI941663A (fi) Trikriittisen pisteen omaava koostumus
ITMI932540A0 (it) Composizione farmaceutica
MX9200622A (es) Composicion farmaceutica
BR9507768A (pt) Composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
FI955605A0 (fi) Aryloivia lääkkeitä
FI973280A0 (fi) Farmaseuttinen koostumus
NO961589D0 (no) Farmasöytiske blandinger
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
KR950703340A (ko) 항엠알에스에이 조성물
BR9605777A (pt) Composição farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
NO964309D0 (no) Farmasöytisk sammensetning
ITMI932543A0 (it) Composizione farmaceutica
BR1100200A (pt) Composição farmacêutica
SE9402924D0 (sv) Novel pharmaceutical composition
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
ITMI922581A1 (it) Composizione farmaceutica
SE9202820D0 (sv) Farmaceutisk komposition
ITMI922580A0 (it) Composizione farmaceutica

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981231